Vancomycin Hikma Farmacêutica (Portugal)

Vancomycin Hikma Farmacêutica (Portugal) is an intravenous antibiotic used to treat serious bacterial infections. It belongs to the glycopeptide class and is prescribed when other antibiotics are ineffective. This EU-manufactured solution is designed for hospital and clinical settings.

Vancomycin is commonly used to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive bacteria. It may also be prescribed for patients allergic to penicillin or with infections unresponsive to other antibiotics. This medication is typically administered in healthcare settings for conditions like pneumonia, endocarditis, and skin infections.

Vancomycin works by interfering with bacterial cell wall formation, leading to bacterial death. Patients may experience relief from infection symptoms such as fever and inflammation as the medication takes effect. The intravenous route ensures rapid systemic distribution to target infection sites.

Vancomycin should be handled with care by healthcare professionals to avoid contamination or improper administration. Patients with kidney issues or hearing problems should inform their provider before use. Regular monitoring of blood levels and kidney function is often recommended during treatment.

Vancomycin may interact with other medications that affect kidney function or hearing, such as certain diuretics or aminoglycosides. Combining it with anesthetics or muscle relaxants can increase the risk of side effects. Alcohol use during treatment is generally discouraged.